Diagnosis of Pelvic Endometriosis in MRI - Trial NCT06157528
Access comprehensive clinical trial information for NCT06157528 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhenshen Ma and is currently Not yet recruiting. The study focuses on Endometriosis. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zhenshen Ma
Qianfoshan Hospital
Timeline & Enrollment
N/A
Dec 20, 2023
Dec 01, 2029
Primary Outcome
Measuring the number of lesions
Summary
Purpose๏ผ Evaluate the feasibility of R2 star multiple fast gradient recalled echo (R2*MFGRE)
 imaging in the diagnosis of pelvic endometriosis.
 
 One hundred patients with suspected endometriosis underwent routine pelvic MRI and R2*MFGRE
 imaging. Clinical diagnosis was pathologically confirmed one month after MRI examination.
 Three radiologists who were blinded to the pathological results evaluated the numbers of
 ovarian endometriomas (OMAs) and deep in-filtrating endometriosis (DIE) lesions using routine
 MRI and its combination with R2*MFGRE. MRI changes of lesion size before and after estrogen
 therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06157528
Non-Device Trial